Clinical Trials Browser

Phase 1/2 × Locally Advanced or Metastatic Solid Tumors × 30 days × Clear all

NCT07469774 2026-05-28

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors